Cell Therapy Approaches Moving Along the Pipeline
Beta cell replacement therapies for type 1 diabetes (T1D) have made significant advances in just the past 10 years. We now have insulin-producing beta cells, derived from stem cells, which makes a donor (needed to provide the beta cells) obsolete. We have seen that stem cell-derived precursors can—once implanted in humans—mature into beta cells and […]
College With Type 1 Diabetes During Coronavirus
Back to school season during the coronavirus pandemic has been met with several challenges, but for college students, preparation is still key, whether on-campus or at home.
Teachers with T1D Talk Back-to-School
Three teachers with type 1 diabetes (T1D) share their perspectives about back-to-school, including their biggest concerns and what they want parents to know.
Accelerating Our Mission and Becoming More Volunteer Powered
Our bold vision for the future outlines strategies to drive greater impact to unlock cures and drive research that improves the lives of people with type one diabetes (T1D).
Executive Orders on Drug Pricing
On July 24, the White House released three Executive Orders related to drug pricing.
Back-to-School with Diabetes: What the Experts Say
Healthcare and education professionals share what parents and educators need to know for a return to school during the COVID-19 pandemic.
15 Signs You’re the Parent of a Kid with Type 1 Diabetes
Just in time for Parents’ Day, we’re highlighting the ways parents and guardians rise to the challenge of helping kids live with and learn to manage type 1 diabetes.
Myth vs. Fact: COVID-19 Can Trigger Diabetes
It’s been around the news: COVID-19 might trigger diabetes, at least in some people. That’s what several Breakthrough T1D-funded scientists posit. But let’s look at the evidence.
Tandem Diabetes Care in the Real World
Two leaders from Tandem Diabetes Care share real-world outcomes from Tandem insulin pump users, other practical insights.
Just Doing Experiments? Well, Ones that May Have Life-Saving Potential
Smart insulin; what is that? It’s the type of insulin that Chandra Bhattacharya, Ph.D., has spent her Breakthrough T1D-funded postdoctoral fellowship—the time right after you receive your doctoral degree, but are not ready for primetime as an assistant professor, yet—to pursue. And she has a lot of shoes to fill. At the Massachusetts Institute of […]
